The primary objective was to demonstrate that basal insulin peglispro (BIL) was non-inferior compared with insulin glargine (GL) for haemoglobin A1c (HbA1c) at 26 weeks with a non-inferiority margin of 0.4
作者：S, Garg；M, Dreyer；H, Jinnouchi；J, Mou；Y, Qu；M L, Hartman；M, Rosilio；S J, Jacober；E J, Bastyr
来源：Diabetes, obesity & metabolism 2016 年 18 Suppl 2卷
